How to Read Female Hormone Blood Test Results

Female hormone blood tests only make sense when you know which cycle day the blood was drawn, because the same hormone can look perfectly normal on one day and alarming on another. A panel that includes FSH, LH, estradiol, progesterone, and possibly AMH or testosterone gives your doctor a snapshot of ovarian function, ovulation status, and pituitary signaling, but each marker has its own “best” testing window and its own set of pitfalls. Understanding the basics of what each number means, and what can throw it off, puts you in a much better position to have a productive conversation with your provider.

Why the Day of Your Cycle Matters

Hormones in the menstrual cycle do not sit at a steady level. Estradiol climbs through the first half of the cycle and peaks just before ovulation. Progesterone is barely detectable in the first half, then surges in the second half after the egg is released. FSH and LH shift too, with LH spiking sharply to trigger ovulation. Because of these swings, clinicians draw “baseline” hormones early in the cycle, typically on day 2 or day 3 of your period, when estradiol and FSH are at their most stable and informative starting points.¹² Progesterone, on the other hand, is checked about a week after ovulation, in the mid-luteal phase, because that is when it peaks high enough to confirm whether you actually ovulated.

If your blood was drawn on the wrong cycle day, the numbers can be misleading. A “low” progesterone on day 8 is completely expected and tells you nothing about ovulation. A “high” estradiol on day 12 might just mean you are approaching ovulation normally. Before you try to interpret any result, check when in your cycle the sample was taken. If your report does not note the cycle day, ask your clinic, because without that context, the numbers are almost uninterpretable.

FSH and LH

Follicle-stimulating hormone and luteinizing hormone are produced by the pituitary gland in your brain, and they tell the ovaries what to do. FSH recruits and grows follicles in the first half of the cycle; LH triggers the release of the mature egg. On a day 2 or 3 blood draw, FSH is the number clinicians pay the most attention to. A low-to-normal early FSH suggests the ovaries are responding well. A rising baseline FSH, especially in women in their late 30s and beyond, suggests the pituitary is working harder to get the ovaries to respond, which is an early sign of declining ovarian reserve.

One tricky thing about FSH is that it can bounce around quite a bit from one cycle to the next, even in the same person. Research tracking women of late reproductive age found that FSH and estradiol showed considerable variation across consecutive cycles, sometimes swinging between low FSH with high estradiol in one cycle and high FSH with low estradiol in the next.³ That means a single elevated FSH reading does not necessarily seal the diagnosis. If your result is borderline, your doctor may want to recheck it the following cycle.

The ratio of LH to FSH also carries information. In a typical cycle, the two are roughly similar on day 3. A notably elevated LH relative to FSH can point toward polycystic ovary syndrome, while a low LH-to-FSH ratio in someone who has stopped menstruating can suggest a different problem called functional hypothalamic amenorrhea, where the brain is under-signaling the ovaries rather than the ovaries failing on their own.⁴

Estradiol

Estradiol (often abbreviated E2 on lab reports) is the primary estrogen your ovaries produce. On day 2 or 3, a low-to-moderate estradiol is what clinicians want to see. If baseline estradiol is already elevated, it can artificially suppress FSH, making FSH look reassuringly low when the ovaries are actually struggling. That is why the two numbers should always be read together: a “normal” FSH paired with an unusually high early estradiol is not as reassuring as it looks.

Several factors influence where your estradiol lands. Age is the biggest one. Body composition matters too: women with lower body mass index tend to have different estradiol-to-FSH dynamics than women with higher body mass.³ Smoking has also been linked to shifts in gonadotropin levels. These are worth flagging for your provider if your estradiol seems off and you are not sure why.

Later in the cycle, rising estradiol simply reflects a growing follicle and is expected. Clinics doing fertility monitoring will track estradiol repeatedly through the follicular phase to gauge follicle development, but for a standard diagnostic panel, the day-3 value is the one that matters most.

Progesterone

Progesterone is the hormone of the second half of the cycle. After ovulation, the collapsed follicle transforms into a structure called the corpus luteum, which pumps out progesterone to prepare the uterine lining for a potential pregnancy. A mid-luteal blood draw, roughly 7 days after ovulation, is the standard way to confirm that ovulation occurred. Research comparing progesterone blood levels to endometrial biopsies concluded that a single well-timed progesterone measurement is actually a better screening method for confirming ovulation than a tissue biopsy.⁵

Most labs use a threshold somewhere around 3 ng/mL (roughly 10 nmol/L) as the minimum to suggest ovulation happened, though many clinicians prefer to see mid-luteal progesterone well above that to feel confident about luteal function. The higher the mid-luteal progesterone, the more robust the ovulation likely was, and studies on ovulation induction have found that higher mid-luteal progesterone is associated with better outcomes.⁶

The timing challenge with progesterone is that “7 days after ovulation” is an estimate. If you ovulated later than you thought, your blood draw might catch a progesterone that is still rising or has already started falling. This is one reason a seemingly low progesterone result does not always mean something is wrong. If you track ovulation with kits or basal body temperature, share that data with your provider so they can judge whether the timing was right.

AMH and Ovarian Reserve

Anti-Müllerian hormone is produced by the small follicles sitting in the ovaries, and it serves as an indirect measure of how many eggs remain. Unlike FSH and estradiol, AMH is relatively stable throughout the menstrual cycle, so it can be drawn on any day. It falls steadily with age. In one study establishing reference ranges for reproductive-age women, median AMH was about 27 pmol/L in the 20-to-25 age group and dropped to below 1 pmol/L in the 46-to-50 age group, with wide normal ranges at every age.⁷

A common misconception about AMH is that it tells you whether you can get pregnant. It does not, at least not directly. AMH reflects the size of the remaining egg pool, which is useful for predicting how you might respond to fertility medications and gives a rough sense of reproductive timeline. But women with low AMH can and do conceive naturally, and women with high AMH are not guaranteed easy pregnancies. High AMH is also a hallmark of PCOS, where many small follicles produce an abundance of the hormone. So a high result is not always good news; it depends on the clinical picture.

Testosterone, SHBG, and Androgen Markers

Testosterone is not just a “male” hormone. Women produce it in the ovaries and adrenal glands, and it plays roles in libido, energy, and muscle maintenance. On a hormone panel, total testosterone is measured, but it often does not tell the whole story. Most testosterone in the blood is bound to a protein called sex hormone-binding globulin (SHBG), which makes it inactive. Only the unbound or “free” fraction is biologically active. SHBG does not just park testosterone on the shelf; it broadly controls how much of your sex hormones can actually do their jobs in tissues throughout the body.⁸

This is why SHBG matters so much for interpreting androgen results. A woman can have a “normal” total testosterone but low SHBG, meaning more of that testosterone is free and active, which can drive symptoms like acne, excess hair growth, and hair thinning. Calculated measures like the free androgen index (FAI) capture this better. Research on women with suspected excess androgens found that nearly 90 percent of those with clinical signs had an elevated FAI, compared to only about 36 percent who had elevated total testosterone alone.⁹ If your total testosterone looks normal but you have symptoms that suggest excess androgens, ask whether your SHBG and free androgen index were checked.

SHBG itself is influenced by many things. Estrogen and thyroid hormone push it up; insulin resistance, obesity, and certain androgens push it down. Birth control pills tend to raise SHBG substantially, which is part of how they reduce acne and hirsutism in PCOS. This interconnection means SHBG is not just a modifier of testosterone; it is a metabolic marker in its own right.

Prolactin and Thyroid Hormones

Prolactin is a pituitary hormone best known for stimulating milk production, but it also regulates the menstrual cycle. Elevated prolactin suppresses the signals that drive ovulation, which is why high prolactin is a routine check in women with irregular or absent periods. In a study of women with elevated prolactin from different causes, more than three-quarters of those with a pituitary prolactinoma had oligomenorrhea (infrequent periods), and the higher the prolactin level, the more severe the menstrual disruption.¹⁰ Certain medications, especially some psychiatric drugs, can also push prolactin up, so a mildly elevated result does not automatically mean a tumor is present.

Thyroid function tests, typically TSH with free T4 and sometimes free T3, are often bundled into a reproductive hormone workup because thyroid hormones and reproductive hormones are tightly linked. Research following premenopausal women found that higher levels of T4 were associated with higher progesterone metabolites in the luteal phase and higher estrogen metabolites in the follicular phase, meaning thyroid status can measurably alter ovarian hormone output.¹¹ Both an underactive and overactive thyroid can cause irregular periods, difficulty conceiving, and early pregnancy loss, which is why thyroid hormones are part of the standard workup even though they are not ovarian hormones.

How Birth Control Changes the Numbers

If you are taking combined oral contraceptives and get a hormone panel, the results will look very different from what your body would produce on its own. The pill suppresses the brain’s hormonal signaling to the ovaries, which drives down FSH and LH substantially. A meta-analysis of contraceptive effects in women with PCOS found that pills containing cyproterone acetate decreased FSH and LH progressively over 3, 6, and 12 months of use, and also lowered estradiol. Pills containing drospirenone similarly decreased FSH and LH at 6 months.¹²

This suppression means you cannot use a hormone panel taken while on the pill to assess your underlying ovarian function. Your FSH might look beautifully low, but that reflects the pill’s effect, not your ovarian reserve. AMH is less affected by the pill than FSH or LH, though there is some evidence that long-term contraceptive use can modestly lower AMH temporarily. If your doctor wants to evaluate your baseline hormonal status, they will typically ask you to stop hormonal contraception for at least one full cycle, sometimes two or three, before drawing blood. This also applies to hormonal IUDs, patches, and rings, though the degree of pituitary suppression varies by method.

Reading Results During Perimenopause

Perimenopause, the years leading up to menopause, is when hormone levels become especially hard to interpret. FSH rises and estradiol falls as the ovaries wind down, but not in a straight line. A study tracking hormone levels through the perimenopausal transition found that FSH and estradiol at a single time point were not a reliable marker of biological menopause, because levels varied widely both between women and within the same woman over time, and any trend was not necessarily one-directional.¹³

What this means practically is that a single FSH of 25 IU/L does not confirm you are in menopause, and a normal FSH does not rule it out. Your provider may repeat the test across several months to look for a pattern. Menopause itself is a clinical diagnosis, defined as 12 consecutive months without a period, not a lab result. The hormones help fill in the picture, but they do not replace the clinical timeline.

When the Pattern Matters More Than Any Single Number

Some of the most important diagnostic questions in reproductive endocrinology come down to pattern recognition across multiple hormones rather than any single high or low value. A good example is the challenge of distinguishing PCOS from functional hypothalamic amenorrhea (FHA) in a woman who has stopped menstruating. Both conditions can present with irregular or absent periods and even similar-looking ovaries on ultrasound. But their hormone profiles point in opposite directions. FHA tends to show low LH, low-to-normal testosterone, and higher SHBG, because the brain is under-stimulating the ovaries. PCOS tends to show elevated LH, higher testosterone, higher AMH, and lower SHBG.¹⁴

Researchers have even developed scoring formulas using the combination of testosterone, SHBG, and LH to separate the two conditions, because no single hormone reliably distinguishes them on its own.⁴ This underscores why looking at your lab report and fixating on one out-of-range value is usually less informative than stepping back and seeing how all the hormones relate to each other. The constellation matters.

Why Reference Ranges Vary Between Labs

If you have had blood work at two different labs and the reference ranges printed on the reports do not match, that is normal and not a mistake. Different labs use different testing equipment and different calibration standards, which can shift where the “normal” boundaries fall. The method used to measure the hormone also matters. Immunoassays, the workhorse technique in most clinical labs, are fast and cheap but can be less precise for certain hormones at low concentrations. A more advanced technique called liquid chromatography-tandem mass spectrometry is considered the gold standard for accuracy, and research has shown it outperforms older immunoassay methods for sex steroid measurement.¹⁵

For most clinical purposes, standard immunoassay blood tests are accurate enough to guide decisions. But if you are comparing results between labs, always compare your number to the reference range printed on that specific report, not to a range you found online or remember from a previous lab.

At-Home and Alternative Testing Methods

Direct-to-consumer hormone testing has become popular, and the methods range from dried blood spots to dried urine panels. Dried blood spot testing, where you prick your finger and blot blood onto a card, has been validated for a range of reproductive hormones including FSH, LH, estradiol, testosterone, prolactin, and SHBG, with results that correlate well to standard venous blood draws.¹⁶ More recent work has confirmed that dried blood spot assays using advanced mass spectrometry methods produce reliable testosterone measurements with strong clinical correlation to serum samples.¹⁷

Dried urine testing takes a different approach, collecting urine samples at multiple points in the day to measure hormone metabolites. Validation work has shown excellent agreement between dried and liquid urine results for reproductive hormones, and good-to-excellent agreement between a four-spot collection and a full 24-hour urine collection.¹⁸ These methods can be convenient for people who want to test at home or who have difficulty with venipuncture.

The practical limitation of at-home tests is interpretation. A lab report mailed to your door without clinical context, without knowing your cycle day, your medication history, or your symptoms, is easy to misread. You might see a flagged value and panic, or see normal values and feel falsely reassured when the issue is actually in how the hormones relate to one another. These tests work best when your provider orders them or at least reviews the results with your full history in hand.